Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests.
Klausberger M, Duerkop M, Haslacher H, Wozniak-Knopp G, Cserjan-Puschmann M, Perkmann T, Lingg N, Aguilar PP, Laurent E, De Vos J, Hofner M, Holzer B, Stadler M, Manhart G, Vierlinger K, Egger M, Milchram L, Gludovacz E, Marx N, Köppl C, Tauer C, Beck J, Maresch D, Grünwald-Gruber C, Strobl F, Satzer P, Stadlmayr G, Vavra U, Huber J, Wahrmann M, Eskandary F, Breyer MK, Sieghart D, Quehenberger P, Leitner G, Strassl R, Egger AE, Irsara C, Griesmacher A, Hoermann G, Weiss G, Bellmann-Weiler R, Loeffler-Ragg J, Borth N, Strasser R, Jungbauer A, Hahn R, Mairhofer J, Hartmann B, Binder NB, Striedner G, Mach L, Weinhäusel A, Dieplinger B, Grebien F, Gerner W, Binder CJ, Grabherr R. Klausberger M, et al. Among authors: binder nb. EBioMedicine. 2021 May;67:103348. doi: 10.1016/j.ebiom.2021.103348. Epub 2021 Apr 25. EBioMedicine. 2021. PMID: 33906067 Free PMC article.
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies.
Egger AE, Sahanic S, Gleiss A, Ratzinger F, Holzer B, Irsara C, Binder N, Winkler C, Binder CJ, Posch W, Loacker L, Hartmann B, Anliker M, Weiss G, Sonnweber T, Tancevski I, Griesmacher A, Löffler-Ragg J, Hoermann G. Egger AE, et al. Microbiol Spectr. 2022 Dec 21;10(6):e0059722. doi: 10.1128/spectrum.00597-22. Epub 2022 Oct 12. Microbiol Spectr. 2022. PMID: 36222681 Free PMC article.
Clinical use of thrombin generation assays.
Binder NB, Depasse F, Mueller J, Wissel T, Schwers S, Germer M, Hermes B, Turecek PL. Binder NB, et al. J Thromb Haemost. 2021 Dec;19(12):2918-2929. doi: 10.1111/jth.15538. Epub 2021 Oct 8. J Thromb Haemost. 2021. PMID: 34592058 Free PMC article. Review.
Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.
Turecek PL, Peck RC, Rangarajan S, Reilly-Stitt C, Laffan MA, Kazmi R, James I, Dushianthan A, Schrenk G, Gritsch H, Ewenstein BM, Mellgard B, Erdlenbruch W, Jain N, Binder NB, Mumford AD. Turecek PL, et al. Among authors: binder nb. Thromb Res. 2021 May;201:100-112. doi: 10.1016/j.thromres.2021.02.012. Epub 2021 Feb 18. Thromb Res. 2021. PMID: 33662796 Free PMC article.
ADAMTS13 Activity: Screening Test Protocol.
Moore GW, Griffiths M, Binder NB. Moore GW, et al. Among authors: binder nb. Methods Mol Biol. 2023;2663:523-531. doi: 10.1007/978-1-0716-3175-1_34. Methods Mol Biol. 2023. PMID: 37204734
ADAMTS13 Antibody and Inhibitor Assays.
Moore GW, Vetr H, Binder NB. Moore GW, et al. Among authors: binder nb. Methods Mol Biol. 2023;2663:549-565. doi: 10.1007/978-1-0716-3175-1_36. Methods Mol Biol. 2023. PMID: 37204736
22 results